Serviço de Reumatologia e Doenças Ósseas Metabólicas, Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa (CAML), 1649-028 Lisboa, Portugal.
Unidade de Investigação em Reumatologia, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, CAML, 1649-028 Lisboa, Portugal.
Nutrients. 2020 Nov 14;12(11):3504. doi: 10.3390/nu12113504.
Rheumatoid arthritis (RA) is a chronic immune-driven inflammatory disease characterised by synovial inflammation, leading to progressive cartilage and bone destruction, impacting patients' functional capacity and quality of life. Patients with RA have significant differences in gut microbiota composition when compared to controls. Intestinal dysbiosis influences the intestinal barrier strength, integrity and function, and diet is considered the main environmental factor impacting gut microbiota. Over the last few years, researchers have focused on the influence of single components of the diet in the modulation of intestinal microbiota in RA rather than whole dietary patterns. In this review, we focus on how the Mediterranean diet (MD), a whole dietary pattern, could possibly act as an adjuvant therapeutic approach, modulating intestinal microbiota and intestinal barrier function in order to improve RA-related outcomes. We also review the potential effects of particular components of the MD, such as n-3 polyunsaturated fatty acids (PUFAs), polyphenols and fibre.
类风湿关节炎(RA)是一种慢性免疫驱动的炎症性疾病,其特征是滑膜炎症,导致进行性软骨和骨破坏,影响患者的功能能力和生活质量。与对照组相比,RA 患者的肠道微生物群落组成存在显著差异。肠道菌群失调影响肠道屏障的强度、完整性和功能,饮食被认为是影响肠道菌群的主要环境因素。在过去的几年中,研究人员专注于研究饮食中的单一成分对 RA 患者肠道微生物群落的调节作用,而不是研究整体饮食模式。在这篇综述中,我们重点探讨了地中海饮食(MD)这种整体饮食模式如何可能作为一种辅助治疗方法,通过调节肠道微生物群落和肠道屏障功能来改善与 RA 相关的结果。我们还回顾了 MD 的特定成分,如 n-3 多不饱和脂肪酸(PUFAs)、多酚和纤维,可能产生的潜在影响。